Coralie de LAMARE

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms